Raymond James Financial Services Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$418M Sell
2,578,984
-42,036
-2% -$6.7M 0.56% 31
2024
Q2
$383M Buy
2,621,020
+41,492
+2% +$6.17M 0.54% 32
2024
Q1
$408M Buy
2,579,528
+88,849
+4% +$14.1M 0.61% 31
2023
Q4
$390M Sell
2,490,679
-109,139
-4% -$16.7M 0.63% 28
2023
Q3
$405M Sell
2,599,818
-103,420
-4% -$17.1M 0.73% 22
2023
Q2
$447M Buy
2,703,238
+89,145
+3% +$14.4M 0.79% 16
2023
Q1
$405M Buy
2,614,093
+202,256
+8% +$32.7M 0.77% 15
2022
Q4
$426M Buy
2,411,837
+18,179
+0.8% +$3.14M 0.86% 12
2022
Q3
$391M Buy
2,393,658
+43,735
+2% +$7.4M 0.87% 12
2022
Q2
$417M Buy
2,349,923
+46,503
+2% +$8.29M 0.91% 9
2022
Q1
$408M Buy
2,303,420
+80,922
+4% +$13.8M 0.77% 14
2021
Q4
$380M Buy
2,222,498
+5,261
+0.2% +$861K 0.71% 16
2021
Q3
$358M Buy
2,217,237
+52,139
+2% +$8.9M 0.73% 16
2021
Q2
$357M Buy
2,165,098
+640,993
+42% +$106M 0.73% 15
2021
Q1
$250M Buy
1,524,105
+66,009
+5% +$10.7M 0.57% 28
2020
Q4
$229M Buy
1,458,096
+37,018
+3% +$5.46M 0.57% 26
2020
Q3
$212M Buy
1,421,078
+13,708
+1% +$2.03M 0.6% 25
2020
Q2
$198M Buy
1,407,370
+103,523
+8% +$15.1M 0.63% 22
2020
Q1
$171M Buy
1,303,847
+25,153
+2% +$3.57M 0.75% 22
2019
Q4
$187M Buy
1,278,694
+100,432
+9% +$13.6M 0.6% 28
2019
Q3
$152M Buy
1,178,262
+62,851
+6% +$8.28M 0.55% 31
2019
Q2
$155M Buy
1,115,411
+19,837
+2% +$2.75M 0.6% 28
2019
Q1
$153M Buy
1,095,574
+20,009
+2% +$2.68M 0.63% 26
2018
Q4
$139M Sell
1,075,565
-92,593
-8% -$12.9M 0.73% 22
2018
Q3
$161M Buy
1,168,158
+44,974
+4% +$5.98M 0.73% 17
2018
Q2
$136M Buy
1,123,184
+38,285
+4% +$4.78M 0.69% 21
2018
Q1
$139M Buy
1,084,899
+59,141
+6% +$7.99M 0.8% 17
2017
Q4
$143M Buy
1,025,758
+47,350
+5% +$6.6M 0.9% 12
2017
Q3
$127M Sell
978,408
-14,626
-1% -$1.94M 0.81% 14
2017
Q2
$131M Buy
993,034
+50,354
+5% +$6.42M 0.91% 10
2017
Q1
$117M Buy
942,680
+35,110
+4% +$4.19M 0.89% 10
2016
Q4
$105M Buy
907,570
+9,579
+1% +$1.11M 0.88% 12
2016
Q3
$106M Buy
897,991
+11,848
+1% +$1.44M 0.94% 9
2016
Q2
$107M Buy
886,143
+15,650
+2% +$1.78M 1.04% 6
2016
Q1
$94.2M Buy
870,493
+92,237
+12% +$9.55M 1.08% 7
2015
Q4
$79.9M Buy
778,256
+86,317
+12% +$8.68M 0.94% 9
2015
Q3
$64.6M Buy
691,939
+518,309
+299% +$50.1M 1.08% 5
2015
Q2
$16.9M Buy
173,630
+27,901
+19% +$2.79M 1.21% 6
2015
Q1
$14.7M Buy
145,729
+5,747
+4% +$584K 0.72% 30
2014
Q4
$14.6M Buy
139,982
+2,691
+2% +$284K 0.76% 23
2014
Q3
$14.6M Sell
137,291
-1,415
-1% -$147K 0.79% 24
2014
Q2
$14.5M Sell
138,706
-121
-0.1% -$12.2K 0.86% 21
2014
Q1
$13.6M Buy
138,827
+20,194
+17% +$1.87M 0.8% 23
2013
Q4
$10.9M Buy
118,633
+949
+0.8% +$87.5K 0.67% 27
2013
Q3
$10.2M Sell
117,684
-232,168
-66% -$20.8M 0.68% 30
2013
Q2
$30M Buy
+349,852
New +$29.7M 0.88% 11

Other funds holding JNJ

Raymond James Financial Services Advisors's JNJ Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q3 2024, selling an estimated $6.7M and leaving 2,578,984 shares worth $418M. The position accounts for 0.56% of the portfolio, ranked #31.

Raymond James Financial Services Advisors first reported a position in JNJ in Q2 2013 and has held it in 46 quarters since. The position peaked at $447M in Q2 2023. 3,882 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Raymond James Financial Services Advisors held 2,578,984 shares of Johnson & Johnson worth $418M as of Q3 2024.
  • Raymond James Financial Services Advisors sold 42,036 Johnson & Johnson shares in Q3 2024, an estimated $6.7M.
  • Johnson & Johnson made up 0.56% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #31 holding.
  • Raymond James Financial Services Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 46 quarters since.
  • Raymond James Financial Services Advisors's Johnson & Johnson position peaked at $447M in Q2 2023.
  • 3,882 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.